EVALUATION OF CLINICAL COURSE AND OUTCOMES IN ZONE I RETINOPATHY OF PREMATURITY IN A TERTIARY CARE INSTITUTE

BHAWNA PARMAR; VIVEK SOM; ADITI DUBEY

doi:10.22159/ajpcr.2024.v17i6.51265

Authors

BHAWNA PARMAR Department of Ophthalmology, SS Medical College, Rewa, Madhya Pradesh, India
VIVEK SOM Department of Ophthalmology, Gandhi Medical College, Bhopal, Madhya Pradesh, India.
ADITI DUBEY Department of Ophthalmology, Gandhi Medical College, Bhopal, Madhya Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2024.v17i6.51265

Keywords:

Zone 1 retinopathy, Retina, Retinopathy of prematurity, Neonates

Abstract

Objectives: The objectives are to study the clinical course and outcomes of Zone I retinopathy of prematurity and also to study the indication of management and the factors affecting the choice of treatment modality.

Methods: The present study was a prospective observational study conducted at the Department of Ophthalmology. All the neonates having Zone I retinopathy of prematurity (ROP) at presentation according to the International Classification of ROP classification were included in the study after obtaining permission from the institutional ethics committee and consent from parents.

Results: In the present study, 526 neonates were screened and ROP was detected in 131 neonates with an incidence of 24.90%. Out of those 131, Zone I ROP was detected in 50 neonates, giving an incidence of 9.50%.

Conclusion: In our study, Type 1 ROP has a variable course with 47.61% who initially had mild-looking disease developed Type 1 ROP requiring treatment. Hence, a proper timely follow-up is also important in these patients, we cannot exclude the probability of ROP based on the first examination, because when they are present, they are very preterm so vascularization is only until Zone I.

Downloads

Download data is not yet available.

References

Vinekar A, Dogra M, Azad RV, Gilbert C, Gopal L, Trese M. The changing scenario of retinopathy of prematurity in middle and low income countries: Unique solutions for unique problems. Indian J Ophthalmol. 2019;67(6):717-19. doi: 10.4103/ijo.IJO_496_19, PMID 31124475

Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000-15: An updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388(10063):3027-35. doi: 10.1016/S0140- 6736(16)31593-8, PMID 27839855

Cao G, Liu J, Liu M. Global, regional, and national incidence and mortality of neonatal preterm birth, 1990-2019. JAMA Pediatr. 2019;176:787-96.

Salmon JF. Kanski’s Clinical Ophthalmology. 9th ed. Amsterdam: Elsevier; 2019. p. 537-8.

Schachat AP. Ryan’s Rretina. 6th ed. Edinburgh, New York: Elsevier; 2018. p. 3376.

Sen P, Abraham S, Jain S, Gopal L, Bhende P. Treatment outcomes of zone 1 retinopathy of prematurity: A study from a tertiary eye care center in South India. Taiwan J Ophthalmol. 2019;89(4):255-61. doi: 10.4103/tjo.tjo_62_18, PMID 31942431

Pandya HK, Faia LJ, Robinson J, Drenser KA. Macular development in aggressive posterior retinopathy of prematurity. Biomed Res Int. 2015;2015:808639. doi: 10.1155/2015/808639, PMID 26167498

Pejawar RK, Bilagi A, Vinekar A, Bilagi P. National Neonatology Foundation’s Evidence based Clinical Practice Guidelines for Retinopathy of Prematurity, NNF India, Guidelines. New Delhi: NNF India; 2010. p. 253-62.

Braimah IZ, Enweronu-Laryea C, Sackey AH, Kenu E, Agyabeng K, Ofori-Adjei IO, et al. Incidence and risk factors of retinopathy of prematurity in Korle-Bu Teaching Hospital: A baseline prospective study. BMJ Open. 2020;10(8):e035341. doi: 10.1136/ bmjopen-2019-035341, PMID 32759242

Fekri Y, Ojaghi H, Momeni N, Amani F. Retinopathy of prematurity in Ardabil, North West of Iran: Prevalence and risk factors. Eur J Transl Myol. 2021;31(4):10063. doi: 10.4081/ejtm.2021.10063, PMID 34761669

Patel SS, Shendurnikar N. Retinopathy of prematurity in India: Incidence, risk factors, outcome and the applicability of current screening criteria. Int J Contemp Pediatr. 2019;6(6):2235-41. doi: 10.18203/2349-3291.ijcp20194698

Prost M. Possibilities of spontaneous regression in active phase of ROP. Klin Oczna. 2003;105(1-2):57-9. 13. Wang ZH, Li YY Liu ZM. Birth weight and gestational age on retinopathy of prematurity in discordant twins in China. Int J Ophthalmol. 2014;7(4):663-7. doi: 10.3980/j.issn.2222-3959.2014.04.14

Ghani MU, Mehboob M, Khan A, Imran M. Efficacy of intravitreal bevacizumab for the treatment of zone I type 1 retinopathy of prematurity. Pak J Med Health Sci. 2018;12(2):713-5.

Katoch D, Dogra MR, Aggarwal K, Sanghi G, Samanta R, Handa S, et al. Posterior zone I retinopathy of prematurity: Spectrum of disease and outcome after laser treatment. Can J Ophthalmol. 2019;54(1):87-93. doi: 10.1016/j.jcjo.2018.03.005, PMID 30851780